| Pubmed ID |
Author |
Year |
Title |
|
21189639
|
Zhu H
|
2001
|
[The change of malondialdehyde and superoxide dismutase in apoptotic granulosa cell of rat PCO].
|
|
21190873
|
Yasar L
|
2011
|
Serum adiponectin levels in high school girls with polycystic ovary syndrome and hyperandrogenism.
|
|
21190977
|
Tan BK
|
2011
|
Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells.
|
|
21190980
|
Ma RC
|
2011
|
Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome.
|
|
21191832
|
Chen ZJ
|
2010
|
Polycystic ovary syndrome.
|
|
21192531
|
Gebel E
|
2010
|
A new shine on an old med. The story of metformin's past, present, and possible future.
|
|
21193185
|
Veras AB
|
2011
|
Sexual dysfunction in patients with polycystic ovary syndrome: clinical and hormonal correlations.
|
|
21193187
|
Ladson G
|
2011
|
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study.
|
|
21193188
|
Soyman Z
|
2011
|
Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
|
|
21193545
|
Kandaraki E
|
2011
|
Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.
|
|
21193614
|
Bloomgarden ZT
|
2011
|
The American Diabetes Association's 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea.
|
|
21194310
|
Stovall DW
|
2011
|
Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
|
|
21196376
|
Lapointe E
|
2011
|
WNT signaling and the regulation of ovarian steroidogenesis.
|
|
21197149
|
Kahal H
|
2011
|
Pharmacological treatment of obesity in patients with polycystic ovary syndrome.
|
|
21198949
|
Chen W
|
2011
|
Acne-associated syndromes: models for better understanding of acne pathogenesis.
|
|
21199038
|
de Sousa G
|
2011
|
Relationships between polysomnographic variables, parameters of glucose metabolism, and serum androgens in obese adolescents with polycystic ovarian syndrome.
|
|
21199270
|
Tan BK
|
2011
|
Phosphoprotein enriched in diabetes gene product (Ped/pea-15) is increased in omental adipose tissue of women with the polycystic ovary syndrome: ex vivo regulation of ped/pea-15 by glucose, insulin and metformin.
|
|
21204821
|
Verrotti A
|
2011
|
Antiepileptic drugs, sex hormones, and PCOS.
|
|
21206344
|
Young IS
|
2010
|
Lipid metabolism.
|
|
21207332
|
Smitz JE
|
2011
|
The promise of in vitro maturation in assisted reproduction and fertility preservation.
|
|
21209024
|
Pellatt LJ
|
2011
|
Phosphorylation and activation of AMP-activated protein kinase (AMPK) by metformin in the human ovary requires insulin.
|
|
21209031
|
Luque-Ram?rez M
|
2011
|
Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome.
|
|
21209034
|
Yang S
|
2011
|
Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
|
|
21209036
|
Rice S
|
2011
|
Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells.
|
|
21209881
|
Eriksen M
|
2010
|
Insulin resistance is not conserved in myotubes established from women with PCOS.
|
|
21210134
|
Ashrafi M
|
2011
|
The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
|
|
21210850
|
Saha L
|
2012
|
Pharmacotherapy of polycystic ovary syndrome--an update.
|
|
21210872
|
Penaforte FR
|
2011
|
Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome.
|
|
21213521
|
Sukcharoen N
|
2004
|
Management ofanovulatory infertility associated with polycystic ovary syndrome (PCOS).
|
|
21213522
|
Weerakiet S
|
2004
|
Polycystic ovary syndrome and the metabolic syndrome.
|
|
21216086
|
Daghestani MH
|
2011
|
Circulating ghrelin levels and the polycystic ovary syndrome: correlation with the clinical, hormonal and metabolic features.
|
|
21221823
|
de Sousa G
|
2012
|
The impact of insulin resistance and hyperandrogenemia on polysomnographic variables in obese adolescents with polycystic ovarian syndrome.
|
|
21228340
|
Yang X
|
2011
|
Cryptotanshinone reverses reproductive and metabolic disturbances in prenatally androgenized rats via regulation of ovarian signaling mechanisms and androgen synthesis.
|
|
21231824
|
Moini A
|
2011
|
A possible role for familial thrombophilia in women with polycystic ovarian syndrome.
|
|
21232840
|
M?nsson M
|
2011
|
Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls.
|
|
21233108
|
Jinno M
|
2011
|
Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology.
|
|
21234853
|
Cho LW
|
2011
|
Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls.
|
|
21240175
|
Akhter S
|
2011
|
Characteristics of infertile couples.
|
|
21243502
|
Tena G
|
2011
|
Ovarian morphology and endocrine function in polycystic ovary syndrome.
|
|
21244650
|
Yang Y
|
2011
|
Is interleukin-18 associated with polycystic ovary syndrome?
|
|
21247239
|
Khattab S
|
2011
|
Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study.
|
|
21247501
|
Qin Y
|
2011
|
Association of basal serum testosterone levels with ovarian response and in vitro fertilization outcome.
|
|
21247558
|
Wild RA
|
2011
|
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis.
|
|
21247566
|
Kilicdag EB
|
2011
|
Polycystic ovary syndrome and increased polyp numbers as risk factors for malignant transformation of endometrial polyps in premenopausal women.
|
|
21251033
|
Baranova A
|
2011
|
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
|
|
21252242
|
Wickham EP 3rd
|
2011
|
Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.
|
|
21252248
|
Manner?s-Holm L
|
2011
|
Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.
|
|
21256780
|
In-Iw S
|
2011
|
Adolescent women and obesity.
|
|
21257877
|
Pectasides M
|
2011
|
Diabetes revealed: multisystem danger.
|
|
21261118
|
Vankov? M
|
2010
|
[Extremely low SHBG level in consequence of Pro156Leu SHBG polymorphism--case reports of two women with polycystic ovary syndrome].
|
|
21262361
|
Sander VA
|
2011
|
Alterations of folliculogenesis in women with polycystic ovary syndrome.
|
|
21262477
|
Bronstein J
|
2011
|
Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought.
|
|
21262871
|
Morteza Taghavi S
|
2011
|
Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism.
|
|
21263450
|
Goodarzi MO
|
2011
|
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.
|
|
21269226
|
Wang A
|
2011
|
Expression of GPR30, ER? and ER? in endometrium during window of implantation in patients with polycystic ovary syndrome: a pilot study.
|
|
21270326
|
Rosencrantz MA
|
2011
|
Clinical evidence for predominance of delta-5 steroid production in women with polycystic ovary syndrome.
|
|
21270384
|
Phelan N
|
2011
|
Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial.
|
|
21271150
|
de Resende LO
|
2010
|
[Concentration of steroid hormones in the follicular fluid of mature and immature ovarian follicles of patients with polycystic ovary syndrome submitted to in vitro fertilization].
|
|
21271161
|
Soares J?nior JM
|
2010
|
[The use of combined oral contraceptives in the polycystic ovary syndrome].
|
|
21271165
|
Gil Junior AB
|
2010
|
[Adrenal androgen participation in the polycystic ovary syndrome].
|
|
21272901
|
Roelfsema F
|
2011
|
Altered multihormone synchrony in obese patients with polycystic ovary syndrome.
|
|
21274294
|
Broder-Fingert S
|
2009
|
Evaluation of adolescents for polycystic ovary syndrome in an urban population.
|
|
21274726
|
Li Q
|
2011
|
Common genetic variation in the 3'-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients.
|
|
21275164
|
Wang XJ
|
2010
|
[Study on the relation between Pi-deficiency pattern and metabolic syndrome in patients with polycystic ovarian syndrome].
|
|
21277073
|
Yasmin E
|
2011
|
Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome.
|
|
21277789
|
Cardozo E
|
2011
|
Metabolic syndrome and oocyte quality.
|
|
21281021
|
Bhathena RK
|
2011
|
Insulin resistance and the long-term consequences of polycystic ovary syndrome.
|
|
21282199
|
Wang H
|
2011
|
A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro.
|
|
21282692
|
Wilson JF
|
2011
|
In the clinic. The polycystic ovary syndrome.
|
|
21282820
|
Kong GW
|
2011
|
Effects of laparoscopic ovarian drilling in treating infertile anovulatory polycystic ovarian syndrome patients with and without metabolic syndrome.
|
|
21283123
|
Grover A
|
2011
|
Metformin or thiazolidinedione therapy in PCOS?
|
|
21283731
|
Ewens KG
|
2011
|
FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome.
|
|
21285103
|
Wisner KL
|
2011
|
Valproate prescription prevalence among women of childbearing age.
|
|
21288501
|
Lamb JD
|
2011
|
Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health associations.
|
|
21294689
|
T?rk??o?lu I
|
2011
|
Independent predictors of cardiovascular risk in polycystic ovarian syndrome.
|
|
21297382
|
Franconi G
|
2011
|
Acupuncture in clinical and experimental reproductive medicine: a review.
|
|
21297528
|
Dasanu CA
|
2011
|
Polycystic ovary syndrome: focus on platelets and prothrombotic risk.
|
|
21298999
|
Hern?ndez-Valencia M
|
2010
|
[Care of insulin resistance in polycystic ovary syndrome].
|
|
21299936
|
Truelsen MK
|
2011
|
[Polycystic ovary syndrome and miscarriage].
|
|
21300335
|
Escobar-Morreale HF
|
2011
|
Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome.
|
|
21300337
|
Bagis T
|
2011
|
Pregnancy in women with PCOS.
|
|
21300338
|
Morgante G
|
2011
|
The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.
|
|
21300343
|
Younis JS
|
2011
|
Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients.
|
|
21300347
|
Goodarzi MO
|
2011
|
Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.
|
|
21306318
|
Vanky E
|
2011
|
PCOS--what matters in early pregnancy?--data from a cross-sectional, multicenter study.
|
|
21306320
|
Kauffman RP
|
2011
|
Serum magnesium concentrations and metabolic variables in polycystic ovary syndrome.
|
|
21306324
|
Amer S
|
2011
|
The impact of insulin resistance on the outcome of laparoscopic ovarian diathermy in women with polycystic ovarian syndrome.
|
|
21306326
|
Abu Hashim H
|
2011
|
Intrauterine insemination versus timed intercourse with clomiphene citrate in polycystic ovary syndrome: a randomized controlled trial.
|
|
21307134
|
Romualdi D
|
2011
|
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
|
|
21310628
|
Smith HA
|
2011
|
A comparison of polycystic ovary syndrome and related factors between lesbian and heterosexual women.
|
|
21311418
|
Dara? E
|
2011
|
Transvaginal hydrolaparoscopy.
|
|
21311419
|
De Seta F
|
2011
|
[Proteomic applications in gynecology-obstetrics].
|
|
21311428
|
Alemzadeh R
|
2011
|
New adolescent polycystic ovary syndrome perspectives.
|
|
21311712
|
Meyer FP
|
2011
|
Step down treatment with antiepileptic drugs.
|
|
21314808
|
Sasaki A
|
2011
|
Increased arterial stiffness in mildly-hypertensive women with polycystic ovary syndrome.
|
|
21316661
|
Yang S
|
2011
|
Serum complement C3 has a stronger association with insulin resistance than high-sensitivity C-reactive protein in women with polycystic ovary syndrome.
|
|
21316662
|
Moran LJ
|
2011
|
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome.
|
|
21316865
|
Alfarouk KO
|
2011
|
Diabetes mellitus type 2 through oncology lens.
|
|
21323584
|
Merkin SS
|
2011
|
Socioeconomic status and polycystic ovary syndrome.
|
|
21324452
|
Redman LM
|
2011
|
Aerobic exercise in women with polycystic ovary syndrome improves ovarian morphology independent of changes in body composition.
|